Cargando…

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

PURPOSE: Although aspirin therapy is used widely in older adults for prevention of cardiovascular disease, its impact on the incidence, progression and severity of age-related macular degeneration (AMD) is uncertain. The effect of low-dose aspirin on the course of AMD will be evaluated in this clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robman, Liubov, Guymer, Robyn, Woods, Robyn, Ward, Stephanie, Wolfe, Rory, Phung, James, Hodgson, Lauren, Makeyeva, Galina, Aung, Khin Zaw, Gilbert, Tom, Lockery, Jessica, Le-Pham, Y-Anh, Orchard, Suzanne, Storey, Elsdon, Abhayaratna, Walter, Reid, Daniel, Ernst, Michael E., Nelson, Mark, Reid, Christopher, McNeil, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518696/ https://www.ncbi.nlm.nih.gov/pubmed/28736754 http://dx.doi.org/10.1016/j.conctc.2017.03.005

Ejemplares similares

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020)

Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trial
por: Wolfe, Rory, et al.
Publicado: (2023)

Overcoming challenges to data quality in the ASPREE clinical trial
por: Lockery, Jessica E., et al.
Publicado: (2019)

Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study
por: Chong, Elaine W., et al.
Publicado: (2015)

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

ASPREE SUB-STUDIES
por: Woods, Robyn L, et al.
Publicado: (2019)

Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial
por: Margolis, Karen L., et al.
Publicado: (2018)

POTENTIAL IMPLICATIONS OF ASPREE ON ASPIRIN PRIMARY PREVENTION GUIDELINES
por: Murray, Anne M
Publicado: (2019)

A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data
por: Neumann, Johannes T, et al.
Publicado: (2022)

THE ASPREE STUDY: DISABILITY-FREE SURVIVAL, UPDATED RESULTS, SUB-STUDIES, AND IMPLICATIONS FOR ASPIRIN USE
por: Murray, Anne M, et al.
Publicado: (2019)

Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)
por: Reid, Christopher M, et al.
Publicado: (2012)

Associations between Metformin and Aspirin Use on Cancer Incidence and Mortality in Older Adults.
por: Orchard, Suzanne, et al.
Publicado: (2021)

Effects of aspirin on the long-term management of depression in older people: A double blind randomized placebo-controlled trial.
por: Berk, Michael., et al.
Publicado: (2021)

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)
por: Muhandiramge, Jaidyn, et al.
Publicado: (2023)

Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
por: Islam, Rakibul M, et al.
Publicado: (2022)

Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
por: Orchard, Suzanne G, et al.
Publicado: (2023)

EFFECT OF INITIATING ASPIRIN ON CANCER EVENTS IN THE HEALTHY ELDERLY
por: Chan, Andrew T, et al.
Publicado: (2019)

Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos
por: Ryan, Joanne, et al.
Publicado: (2020)

AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
por: Eisen, Damon P, et al.
Publicado: (2017)

Sleep‐disordered breathing was associated with lower health‐related quality of life and cognitive function in a cross‐sectional study of older adults
por: Ward, Stephanie A., et al.
Publicado: (2022)

RATIONALE FOR ASPREE DISABILITY-FREE SURVIVAL PRIMARY OUTCOME AND OVERVIEW OF PRIMARY OUTCOME RESULTS
por: McNeil, John
Publicado: (2019)

Gait Speed and Grip Strength Are Predictors of Cognitive Decline and Dementia in Older Individuals.
por: Orchard, Suzanne, et al.
Publicado: (2021)

Combination of gait speed and grip strength to predict cognitive decline and dementia
por: Orchard, Suzanne G., et al.
Publicado: (2022)

ASPIRIN BENEFIT IS NOT AFFECTED BY BODY WEIGHT IN HEALTHY OLDER PERSONS
por: Woods, Robyn L, et al.
Publicado: (2019)

Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
por: McNeil, John J, et al.
Publicado: (2020)

Socio-Demographic, Lifestyle, and Clinical Characteristics of Early and Later Weight Status in Older Adults: Secondary Analysis of the ASPREE Trial and ALSOP Sub-Study
por: Alharbi, Tagrid A., et al.
Publicado: (2023)

Dementia Adjudication Triggers Associated With Increased Mortality for Older Australians: Evidence From ASPREE
por: Banaszak-Holl, Jane, et al.
Publicado: (2020)

THE ASPREE STUDY: DEMENTIA DUE TO ALZHEIMER’S DISEASE OUTCOMES
por: Shah, Raj C
Publicado: (2019)

Trajectories of cognitive function in community‐dwelling older adults: A longitudinal study of population heterogeneity
por: Wu, Zimu, et al.
Publicado: (2021)

Potential modifiable factors associated with late-life cognitive trajectories
por: Wu, Zimu, et al.
Publicado: (2022)

The Effect of Low-Dose Aspirin on Frailty in Older Adults in the Aspirin in Reducing Events in the Elderly Study
por: Espinoza, Sara, et al.
Publicado: (2021)

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population
por: Riaz, Moeen, et al.
Publicado: (2021)

Trajectories of cognitive function and associated factors in community-dwelling older adults: a prospective study
por: Wu, Zimu, et al.
Publicado: (2021)

Cognitive Trajectories in Community-Dwelling Older Adults and Incident Dementia, Disability and Death: A 10-Year Longitudinal Study
por: Wu, Zimu, et al.
Publicado: (2022)

Grip strength, gait speed, and trajectories of cognitive function in community‐dwelling older adults: A prospective study
por: Wu, Zimu, et al.
Publicado: (2023)

Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial
por: Cloud, Geoffrey C., et al.
Publicado: (2023)

Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study
por: McCarty, Catherine A, et al.
Publicado: (2008)

Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Guymer, Robyn H, et al.
Publicado: (2008)

POTENTIALLY INAPPROPRIATE MEDICATION USE INCREASES RISK OF INCIDENT DISABILITY IN HEALTHY OLDER ADULTS
por: Lockery, Jessica, et al.
Publicado: (2022)

Long‐Term Blood Pressure Variability and Risk of Cognitive Decline and Dementia Among Older Adults
por: Ernst, Michael E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_355irkkscom3lopcao2d21sup8